Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6398)
All Articles published online
|
Oct 21, 2010 (publication date) through Apr 30, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Navaneethan U, Venkatesh PG, Shen B. |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i39/4892.htm |
| Number | Citing Articles |
| 1 |
F De Luca, Y Shoenfeld. The microbiome in autoimmune diseases. Clinical and Experimental Immunology 2018; 195(1): 74 doi: 10.1111/cei.13158
|
| 2 |
Petros Zezos, Fred Saibil. Inflammatory pouch disease: The spectrum of pouchitis. World Journal of Gastroenterology 2015; 21(29): 8739-8752 doi: 10.3748/wjg.v21.i29.8739
|
| 3 |
Geeta Kulkarni, Bo Shen. Atlas of Endoscopy Imaging in Inflammatory Bowel Disease. 2020; : 353 doi: 10.1016/B978-0-12-814811-2.00023-2
|
| 4 |
Prashanna Balaji Venkatasubramanian, Els Oosterink, Monic M. M. Tomassen, Maria Suarez-Diez, Jurriaan J. Mes, Edoardo Saccenti, Nicole J. W. de Wit. Transcriptome-based identification of the beneficial role of blackcurrant, strawberry and yellow onion to attenuate the cytopathic effects of Clostridium difficile toxins. Journal of Berry Research 2021; 11(2): 231 doi: 10.3233/JBR-200646
|
| 5 |
Sai-Long Zhang, Shu-Na Wang, Chao-Yu Miao. Influence of Microbiota on Intestinal Immune System in Ulcerative Colitis and Its Intervention. Frontiers in Immunology 2017; 8 doi: 10.3389/fimmu.2017.01674
|
| 6 |
Cristiana De Musis, Lucia Granata, Marcello Dallio, Agnese Miranda, Antonietta G. Gravina, Marco Romano. Inflammatory Bowel Diseases: The Role of Gut Microbiota. Current Pharmaceutical Design 2020; 26(25): 2951 doi: 10.2174/1381612826666200420144128
|
| 7 |
Christoph Becker, Markus F. Neurath, Stefan Wirtz. The Intestinal Microbiota in Inflammatory Bowel Disease. ILAR Journal 2015; 56(2): 192 doi: 10.1093/ilar/ilv030
|
| 8 |
Revital Kariv, Udayakumar Navaneethan, Preethi G.K. Venkatesh, Rocio Lopez, Bo Shen. Impact of Clostridium difficile infection in patients with ulcerative colitis. Journal of Crohn's and Colitis 2011; 5(1): 34 doi: 10.1016/j.crohns.2010.09.007
|
| 9 |
Udayakumar Navaneethan, Saurabh Mukewar, Preethi GK Venkatesh, Rocio Lopez, Bo Shen. Clostridium difficile infection is associated with worse long term outcome in patients with ulcerative colitis. Journal of Crohn's and Colitis 2012; 6(3): 330 doi: 10.1016/j.crohns.2011.09.005
|
| 10 |
Current World Literature. Current Opinion in Neurology 2011; 24(3): 300 doi: 10.1097/WCO.0b013e328347b40e
|
| 11 |
Henning Sommermeyer, Jacek Piątek. Clostridioides difficile. 2021; : 49 doi: 10.1007/978-3-030-81100-6_5
|
| 12 |
Victor O. Badger, Nate A. Ledeboer, Mary Beth Graham, Charles E. Edmiston. Clostridium difficile. Journal of Parenteral and Enteral Nutrition 2012; 36(6): 645 doi: 10.1177/0148607112446703
|
| 13 |
Meeta Desai, Kristin Knight, James M. Gray, Vu Nguyen, James Boone, Dario Sorrentino. Low glutamate dehydrogenase levels are associated with colonization in Clostridium difficile PCR-only positive patients with inflammatory bowel disease. European Journal of Gastroenterology & Hepatology 2020; 32(9): 1099 doi: 10.1097/MEG.0000000000001762
|
| 14 |
Mohammad Abdehagh, Masoumeh Azimirad, Hamidreza Houri, Banafsheh Nadalian, Fahimeh Azimirad, Meysam Olfatifar, Ome Kolsoum Nasir Shoeibi, Abbas Yadegar, Shabnam Shahrokh, Mehran Mahdavi Roshan, Hamid Asadzadeh Aghdaei, Mohammad Reza Zali. Serum procalcitonin levels associate with Clostridioides difficile infection in patients with inflammatory bowel disease. BMC Infectious Diseases 2021; 21(1) doi: 10.1186/s12879-021-06804-2
|
| 15 |
Henry A. Horton, Gil Y. Melmed. Clostridium difficile in Inflammatory Bowel Disease. Seminars in Colon and Rectal Surgery 2012; 23(2): 65 doi: 10.1053/j.scrs.2012.02.004
|
| 16 |
Angela Vassallo, Mai-Chi N Tran, Ellie JC Goldstein. Clostridium difficile: improving the prevention paradigm in healthcare settings. Expert Review of Anti-infective Therapy 2014; 12(9): 1087 doi: 10.1586/14787210.2014.942284
|
| 17 |
Gabriela Muniz Carvalho, Carolina Pantuzza Ramos, Francisco Carlos Faria Lobato, Roberto Maurício Carvalho Guedes, Paula Roberta Giaretta, Rodrigo Otávio Silveira Silva. Laboratory diagnosis of Clostridioides (Clostridium) difficile infection in domestic animals: A short review. Anaerobe 2022; 75: 102574 doi: 10.1016/j.anaerobe.2022.102574
|
| 18 |
Esi S.N. Lamousé‐Smith, Sarah Weber, Richard F. Rossi, Liliane J. Neinstedt, Nima Mosammaparast, Thomas J. Sandora, Alexander J. McAdam, Athos Bousvaros. Polymerase Chain Reaction Test for Clostridium difficile Toxin B Gene Reveals Similar Prevalence Rates in Children With and Without Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition 2013; 57(3): 293 doi: 10.1097/MPG.0b013e3182999990
|
| 19 |
Sandra Dedrick, Bharathi Sundaresh, Qian Huang, Claudia Brady, Tessa Yoo, Catherine Cronin, Caitlin Rudnicki, Michael Flood, Babak Momeni, Johnny Ludvigsson, Emrah Altindis. The Role of Gut Microbiota and Environmental Factors in Type 1 Diabetes Pathogenesis. Frontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.00078
|
| 20 |
Hiroyuki Kunishima, Hiroki Ohge, Hiromichi Suzuki, Atsushi Nakamura, Kazuaki Matsumoto, Hiroshige Mikamo, Nobuaki Mori, Yoshitomo Morinaga, Katsunori Yanagihara, Yuka Yamagishi, Sadako Yoshizawa. Japanese Clinical Practice Guidelines for Management of Clostridioides (Clostridium) difficile infection. Journal of Infection and Chemotherapy 2022; 28(8): 1045 doi: 10.1016/j.jiac.2021.12.011
|
| 21 |
Kelly C. Sandberg, Matthew M. Davis, Achamyeleh Gebremariam, Jeremy Adler. Increasing Hospitalizations in Inflammatory Bowel Disease Among Children in the United States, 1988–2011. Inflammatory Bowel Diseases 2014; 20(10): 1754 doi: 10.1097/MIB.0000000000000195
|
| 22 |
Lena M. Napolitano, Charles E. Edmiston. Clostridium difficile disease: Diagnosis, pathogenesis, and treatment update. Surgery 2017; 162(2): 325 doi: 10.1016/j.surg.2017.01.018
|
| 23 |
Parisa Shoaei, Hasan Shojaei, Mohammad Jalali, Farzin Khorvash, Sayed Mohsen Hosseini, Behrooz Ataei, Bahareh Vakili, Fatemeh Ebrahimi, Hossein Tavakoli, Zahra Esfandiari, J. Scott Weese. Clostridium difficile isolated from faecal samples in patients with ulcerative colitis. BMC Infectious Diseases 2019; 19(1) doi: 10.1186/s12879-019-3965-8
|
| 24 |
Massimo Martinelli, Caterina Strisciuglio, Gabor Veres, Anders Paerregaard, Ana M. Pavic, Marina Aloi, Javier Martín-de-Carpi, Arie Levine, Dan Turner, Mariassunta Del Pezzo, Annamaria Staiano, Erasmo Miele. Clostridium difficile and Pediatric Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2014; 20(12): 2219 doi: 10.1097/MIB.0000000000000219
|
| 25 |
Aleksandra Sobolewska-Włodarczyk, Marcin Włodarczyk. Introduction to Gastrointestinal Diseases Vol. 1. 2017; : 83 doi: 10.1007/978-3-319-49016-8_6
|
| 26 |
Francesca McDonagh, Martin Cormican, Dearbháile Morris, Liam Burke, Nitin Kumar Singh, Kasthuri Venkateswaran, Georgios Miliotis. Medical Astro-Microbiology: Current Role and Future Challenges. Journal of the Indian Institute of Science 2023; 103(3): 771 doi: 10.1007/s41745-023-00360-1
|
| 27 |
Leslie Sangurima, Maujid Masood Malik, Nency Ganatra, Rosemary Siby, Sanjay Kumar, Sara Khan, Doju Cheriachan, Lubna Mohammed. Clostridioides difficile Infection in Inflammatory Bowel Disease Patients: A Systematic Review of Risk Factors and Approach in Management. Cureus 2023; doi: 10.7759/cureus.43134
|
| 28 |
Anže Smole, Duško Lainšček, Urban Bezeljak, Simon Horvat, Roman Jerala. A Synthetic Mammalian Therapeutic Gene Circuit for Sensing and Suppressing Inflammation. Molecular Therapy 2017; 25(1): 102 doi: 10.1016/j.ymthe.2016.10.005
|
| 29 |
Yongchun Li, Lili Sheng, Prasant Kumar Jena, Miranda Claire Gilbert, Yu-Jui Yvonne Wan, Hua Mao. Retinoic Acid Signaling Is Compromised in DSS-Induced Dysbiosis. Nutrients 2022; 14(14): 2788 doi: 10.3390/nu14142788
|
| 30 |
Sheng-Bo Fang, Yan-Qing Song, Chun-Yan Zhang, Li-Bo Wang. Risk factors for Clostridioides difficile infection in children and adolescents with inflammatory bowel disease: a systematic review and meta-analysis. World Journal of Pediatrics 2022; 18(1): 27 doi: 10.1007/s12519-021-00486-1
|
| 31 |
Torsten Kucharzik, Christian Maaser. Infections and Chronic Inflammatory Bowel Disease. Visceral Medicine 2014; 30(5): 326 doi: 10.1159/000366463
|
| 32 |
Rodrigo Otávio Silveira Silva, Carlos Augusto de Oliveira Júnior, Dominique S. Blanc, Silvia Trindade Pereira, Mário Cesar Rennó de Araujo, Artur Vasconcelos, Francisco Carlos Faria Lobato. Clostridioides difficile infection in dogs with chronic-recurring diarrhea responsive to dietary changes. Anaerobe 2018; 51: 50 doi: 10.1016/j.anaerobe.2018.03.011
|
| 33 |
Chao Sun, Peng Du, Xian-rui Wu, Elaine Queener, Bo Shen. Preoperative Clostridium difficile Infection Is Not Associated with an Increased Risk for the Infection in Ileal Pouch Patients. Digestive Diseases and Sciences 2014; 59(6): 1262 doi: 10.1007/s10620-014-3047-0
|
| 34 |
Siân Bill, Angharad Dwynwen Barklam. Nursing Care of Children and Young People with Long‐Term Conditions. 2020; : 1 doi: 10.1002/9781119653134.ch1
|
| 35 |
Yuying Liu, Jasmin Freeborn, Shabba A. Armbrister, Dat Q. Tran, Jon Marc Rhoads. Treg-associated monogenic autoimmune disorders and gut microbial dysbiosis. Pediatric Research 2022; 91(1): 35 doi: 10.1038/s41390-021-01445-2
|
| 36 |
Giuseppe Lippi, Fabian Sanchis-Gomar. Procalcitonin in inflammatory bowel disease: Drawbacks and opportunities. World Journal of Gastroenterology 2017; 23(47): 8283-8290 doi: 10.3748/wjg.v23.i47.8283
|
| 37 |
Angela Y. Lam, Liat S. Gutin, Yume Nguyen, Fernando S. Velayos. Management of Recurrent Clostridioides Infection: A Difficile Problem in Inflammatory Bowel Disease Patients. Digestive Diseases and Sciences 2020; 65(11): 3111 doi: 10.1007/s10620-020-06521-x
|
| 38 |
Joana Costa Antunes, Catarina Leal Seabra, Joana Margarida Domingues, Marta Oliveira Teixeira, Cláudia Nunes, Sofia Antunes Costa-Lima, Natália Cândido Homem, Salette Reis, Maria Teresa Pessoa Amorim, Helena Prado Felgueiras. Drug Targeting of Inflammatory Bowel Diseases by Biomolecules. Nanomaterials 2021; 11(8): 2035 doi: 10.3390/nano11082035
|
| 39 |
Nitsan Maharshak, Idan Barzilay, Hasya Zinger, Keren Hod, Iris Dotan. Clostridium difficile infection in hospitalized patients with inflammatory bowel disease. Medicine 2018; 97(5): e9772 doi: 10.1097/MD.0000000000009772
|
| 40 |
Khyati Girdhar, Qian Huang, I-Ting Chow, Tommi Vatanen, Claudia Brady, Amol Raisingani, Patrick Autissier, Mark A. Atkinson, William W. Kwok, C. Ronald Kahn, Emrah Altindis. A gut microbial peptide and molecular mimicry in the pathogenesis of type 1 diabetes. Proceedings of the National Academy of Sciences 2022; 119(31) doi: 10.1073/pnas.2120028119
|
| 41 |
Yang Song, Shashank Garg, Mohit Girotra, Cynthia Maddox, Erik C. von Rosenvinge, Anand Dutta, Sudhir Dutta, W. Florian Fricke, Gabriele Berg. Microbiota Dynamics in Patients Treated with Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection. PLoS ONE 2013; 8(11): e81330 doi: 10.1371/journal.pone.0081330
|
| 42 |
Lauren E. Fuess, Stijn den Haan, Fei Ling, Jesse N. Weber, Natalie C. Steinel, Daniel I. Bolnick, John F. Rawls, Margaret J. McFall-Ngai. Immune Gene Expression Covaries with Gut Microbiome Composition in Stickleback. mBio 2021; 12(3) doi: 10.1128/mBio.00145-21
|
| 43 |
Mi Na Kim, Seong-Joon Koh, Jung Mogg Kim, Jong Pil Im, Hyun Chae Jung, Joo Sung Kim. <italic>Clostridium difficile</italic> infection aggravates colitis in interleukin 10-deficient mice. World Journal of Gastroenterology 2014; 20(45): 17084-17091 doi: 10.3748/wjg.v20.i45.17084
|
| 44 |
Rahul S. Dalal, Jessica R. Allegretti. Diagnosis and management of Clostridioides difficile infection in patients with inflammatory bowel disease. Current Opinion in Gastroenterology 2021; 37(4): 336 doi: 10.1097/MOG.0000000000000739
|
| 45 |
Rosario Lucas López, María José Grande Burgos, Antonio Gálvez, Rubén Pérez Pulido. The human gastrointestinal tract and oral microbiota in inflammatory bowel disease: a state of the science review. APMIS 2017; 125(1): 3 doi: 10.1111/apm.12609
|
| 46 |
Manuela G. Neuman, Radu M. Nanau. Inflammatory bowel disease: role of diet, microbiota, life style. Translational Research 2012; 160(1): 29 doi: 10.1016/j.trsl.2011.09.001
|
| 47 |
J. Michael Klatte, Rangaraj Selvarangan, Mary Anne Jackson, Angela L. Myers. Reducing Overutilization of Testing for Clostridium difficile Infection in a Pediatric Hospital System: A Quality Improvement Initiative. Hospital Pediatrics 2016; 6(1): 9 doi: 10.1542/hpeds.2015-0116
|
| 48 |
Parul Berry, Sahil Khanna. Recurrent Clostridioides difficile Infection: Current Clinical Management and Microbiome-Based Therapies. BioDrugs 2023; 37(6): 757 doi: 10.1007/s40259-023-00617-2
|
| 49 |
Allan Mabardy, Justin Mccarty, Alan Hackford, Haisar Dao. IBD: A Growing and Vulnerable Cohort of Hospitalized Patients with Clostridium difficile Infection. The American Surgeon 2017; 83(6): 605 doi: 10.1177/000313481708300625
|
| 50 |
Ying M. Tang, Christian D. Stone. Clostridium difficile infection in inflammatory bowel disease: challenges in diagnosis and treatment. Clinical Journal of Gastroenterology 2017; 10(2): 112 doi: 10.1007/s12328-017-0719-2
|
| 51 |
Jae Hee Cheon, Won Ho Kim. Atlas of Inflammatory Bowel Diseases. 2015; : 1 doi: 10.1007/978-3-642-39423-2_1
|
| 52 |
Israr Khan, Naeem Ullah, Lajia Zha, Yanrui Bai, Ashiq Khan, Tang Zhao, Tuanjie Che, Chunjiang Zhang. Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome. Pathogens 2019; 8(3): 126 doi: 10.3390/pathogens8030126
|
| 53 |
Anita Krishnarao, Lauren de Leon, Renee Bright, Heather Moniz, Meaghan Law, Neal Leleiko, Bruce E. Sands, Marjorie Merrick, Jason Shapiro, Sylvan Wallenstein, Julie Giacalone, Samir A. Shah. Testing for Clostridium difficile in Patients Newly Diagnosed with Inflammatory Bowel Disease in a Community Setting. Inflammatory Bowel Diseases 2015; 21(3): 564 doi: 10.1097/MIB.0000000000000309
|
| 54 |
Leon M. T. Dicks, Lasse S. Mikkelsen, Erik Brandsborg, Harold Marcotte. Clostridium difficile, the Difficult “Kloster” Fuelled by Antibiotics. Current Microbiology 2019; 76(6): 774 doi: 10.1007/s00284-018-1543-8
|
| 55 |
David Elisha Henry, V. Venkateswara Rao. Probiotic Research in Therapeutics. 2021; : 141 doi: 10.1007/978-981-33-6236-9_6
|
| 56 |
Dipesh Solanky, Darrell S Pardi, Edward V Loftus, Sahil Khanna. Colon Surgery Risk With Corticosteroids Versus Immunomodulators or Biologics in Inflammatory Bowel Disease Patients With Clostridium difficile Infection. Inflammatory Bowel Diseases 2019; 25(3): 610 doi: 10.1093/ibd/izy291
|
| 57 |
Anaberta Bermúdez Naveira, María Mercedes Liñares Paz, Carmen Villalba Martín, Antonio Luna. Learning Abdominal Imaging. Learning Imaging 2012; : 201 doi: 10.1007/978-3-540-88003-5_9
|
| 58 |
Femke-Anouska Heinsen, Henrik Knecht, Sven C Neulinger, Ruth A Schmitz, Carolin Knecht, Tanja Kühbacher, Philip C Rosenstiel, Stefan Schreiber, Anette K Friedrichs, Stephan J Ott. Dynamic changes of the luminal and mucosa-associated gut microbiota during and after antibiotic therapy with paromomycin. Gut Microbes 2015; 6(4): 243 doi: 10.1080/19490976.2015.1062959
|
| 59 |
Daryl D. DePestel, David M. Aronoff. Epidemiology of Clostridium difficile Infection. Journal of Pharmacy Practice 2013; 26(5): 464 doi: 10.1177/0897190013499521
|
| 60 |
Israr Khan, Yanrui Bai, Naeem Ullah, Guanlan Liu, Muhammad Shahid Riaz Rajoka, Chunjiang Zhang, Jiong Yu. Differential Susceptibility of the Gut Microbiota to DSS Treatment Interferes in the Conserved Microbiome Association in Mouse Models of Colitis and Is Related to the Initial Gut Microbiota Difference. Advanced Gut & Microbiome Research 2022; 2022: 1 doi: 10.1155/2022/7813278
|
| 61 |
Walter Reinisch, Andrew R. Reinink, Peter D.R. Higgins. Factors Associated With Poor Outcomes in Adults With Newly Diagnosed Ulcerative Colitis. Clinical Gastroenterology and Hepatology 2015; 13(4): 635 doi: 10.1016/j.cgh.2014.03.037
|
| 62 |
Gabie K.B. Ong, Tobi J. Reidy, Matthew D. Huk, Frederick R. Lane. Clostridium difficile colitis: A clinical review. The American Journal of Surgery 2017; 213(3): 565 doi: 10.1016/j.amjsurg.2016.10.035
|
| 63 |
Meng-Xia Wang, Li Lin, Yong-Da Chen, Yu-Ping Zhong, Yi-Xuan Lin, Pei Li, Xing Tian, Bo Han, Zhi-Yong Xie, Qiong-Feng Liao. Evodiamine has therapeutic efficacy in ulcerative colitis by increasing Lactobacillus acidophilus levels and acetate production. Pharmacological Research 2020; 159: 104978 doi: 10.1016/j.phrs.2020.104978
|
| 64 |
D. S. Purgina, L. V. Lyalina, V. V. Rassokhin. Clostridium diffi cile infection and its eff ect on the course of infl ammatory bowel diseases. Clinical Medicine (Russian Journal) 2022; 100(7-8): 346 doi: 10.30629/0023-2149-2022-100-7-8-346-356
|